{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:45:08Z","timestamp":1787010308877,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The cancer specificity of fibroblast activation protein inhibitor (FAPI) uptake remains understudied topic, and several cases of false-positive FAPI PET\/CT findings have been reported. We present 2 patients of differentiated thyroid cancer with thyroglobulin elevation and negative iodine scintigraphy syndrome who underwent\n                    <jats:sup>68<\/jats:sup>\n                    Ga-FAPI PET\/CT and\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT for evaluation of any possible sites for metastatic disease. Although no focus of metastatic disease was found in these patients, remarkable findings were noticed instead. Nonmalignant FAPI uptake was evident in the gallbladder, uterus, and degenerative changes, whereas these uptake were discordant or partially concordant with those in FDG\u2019s, also CT images showed no underlying abnormality.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000005160","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T10:01:04Z","timestamp":1710151264000},"page":"e213-e214","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Nonmalignant 68Ga-FAPI-46 Uptake in 2 Cases of TENIS Syndrome"],"prefix":"10.1097","volume":"49","author":[{"given":"Farivash","family":"Karamian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atena","family":"Aghaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emran","family":"Askari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hessamoddin","family":"Roustaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","article-title":"A tumor-imaging method targeting cancer-associated fibroblasts","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2967\/jnumed.120.256271","article-title":"FAPI PET\/CT: will it end the hegemony of 18F-FDG in oncology?","volume":"62","year":"2021","journal-title":"J Nucl Med"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"3948873","DOI":"10.1155\/2022\/3948873","article-title":"Could fibroblast activation protein (FAP)-specific radioligands be considered as pan-tumor agents?","volume":"2022","year":"2022","journal-title":"Contrast Media Mol Imaging"},{"key":"bib4-20250621","first-page":"9750080","article-title":"FAPI-04 uptake in healthy tissues of cancer patients in 68Ga-FAPI-04 PET\/CT imaging","volume":"2021","year":"2021","journal-title":"Contrast Media Mol Imaging"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1053\/j.semnuclmed.2023.02.001","article-title":"FAPI-avid nonmalignant PET\/CT findings: an expedited systematic review","volume":"53","year":"2023","journal-title":"Semin Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"989595","DOI":"10.3389\/fonc.2022.989595","article-title":"Non-tumoral uptake of 68Ga-FAPI-04 PET: a retrospective study","volume":"12","year":"2022","journal-title":"Front Oncol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/RLU.0000000000003968","article-title":"Uterine uptake of 68Ga-FAPI-04 in uterine pathology and physiology","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1097\/RLU.0000000000004955","article-title":"FAPI uptake in gallbladder is it normal biodistribution?","volume":"49","year":"2024","journal-title":"Clin Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/RLU.0000000000003621","article-title":"Increased 68Ga-FAPI uptake in chronic cholecystitis and degenerative osteophyte","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s00259-020-05090-5","article-title":"Elevated [68Ga]Ga-DOTA-FAPI-04 activity in degenerative osteophyte in a patient with lung cancer","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00259-021-05472-3","article-title":"Increased uptake of 68Ga-DOTA-FAPI-04 in bones and joints: metastases and beyond","volume":"49","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/RLU.0000000000004416","article-title":"68Ga-DOTA-FAPI-04 PET\/CT imaging in a case of radioactive iodine\u2013induced chronic parotitis","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"e577","DOI":"10.1097\/RLU.0000000000004884","article-title":"Unilateral chronic parotitis with 68 Ga-DOTA-FAPI-04 PET\/CT and 18 F-FDG PET\/CT imaging in a case of a patient with papillary thyroid carcinoma","volume":"48","year":"2023","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005160","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T15:04:12Z","timestamp":1750518252000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005160"}},"subtitle":["Comparison With 18F-FDG"],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005160","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,6]]}}}